NASDAQ: MNPRMonopar Therapeutics Stock Ownership - Who owns Monopar Therapeutics?
Insider buying vs selling
Have Monopar Therapeutics insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Tactic Pharma LLC | Chief Executive Officer | 2025-04-02 | 33,334 | $35.00 | $1.17MSell |
| Andrew Cittadine | Chief Operating Officer | 2025-03-31 | 744 | $36.41 | $27.09kSell |
| Chandler Robinson | Chief Executive Officer | 2025-03-31 | 1,204 | $36.41 | $43.84kSell |
| Chandler Robinson | Chief Executive Officer | 2025-03-04 | 1,759 | $31.70 | $55.76kSell |
| Andrew Cittadine | Chief Operating Officer | 2024-12-31 | 721 | $22.00 | $15.86kSell |
| Chandler Robinson | Chief Executive Officer | 2024-12-31 | 2,209 | $22.00 | $48.60kSell |
| Karthik Radhakrishnan | Chief Financial Officer | 2024-10-28 | 1,550 | $16.25 | $25.19kBuy |
| Chandler Robinson | Chief Executive Officer | 2024-09-30 | 1,918 | $6.74 | $12.93kSell |
| Andrew Cittadine | Chief Operating Officer | 2024-09-30 | 535 | $6.74 | $3.61kSell |
| Kim R. Tsuchimoto | Chief Financial Officer | 2024-06-30 | 2,998 | $0.73 | $2.19kSell |
MNPR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MNPR insiders and whales buy or sell their stock.
MNPR Shareholders
What type of owners hold Monopar Therapeutics stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Arthur J. Klausner | 150.46% | 9,197,045 | $364.11M | Insider |
| Tactic Pharma LLC | 80.71% | 4,933,528 | $195.32M | Insider |
| Michael J. 1. Brown | 78.62% | 4,805,470 | $190.25M | Insider |
| Janus Henderson Group PLC | 17.13% | 1,046,899 | $41.45M | Institution |
| Chandler Robinson | 15.08% | 921,582 | $36.49M | Insider |
| Adage Capital Partners GP LLC | 9.80% | 599,195 | $23.72M | Institution |
| Ra Capital Management LP | 8.36% | 511,207 | $20.24M | Institution |
| Andrew Paul Mazar | 3.09% | 188,792 | $7.47M | Insider |
| Christopher M. Starr | 2.85% | 174,063 | $6.89M | Insider |
| Point72 Asset Management LP | 2.75% | 167,892 | $6.65M | Institution |
MNPR vs Biotech Stocks
Monopar Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.